Mellor SL - Search Results

1

Loss of the expression and localization of inhibin alpha-subunit in high grade prostate cancer.

Mellor SL, Richards MG, Pedersen JS, Robertson DM, Risbridger GP. Mellor SL, et al. J Clin Endocrinol Metab. 1998 Mar;83(3):969-75. doi: 10.1210/jcem.83.3.4640. J Clin Endocrinol Metab. 1998. PMID: 9506758 Review.

2

Cancer progression: is inhibin alpha from Venus or Mars?

Ball EM, Mellor SL, Risbridger GP. Ball EM, et al. Among authors: mellor sl. Cytokine Growth Factor Rev. 2004 Oct;15(5):291-6. doi: 10.1016/j.cytogfr.2004.04.004. Cytokine Growth Factor Rev. 2004. PMID: 15450247 Review.

3

Inhibins, activins, and follistatins: expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia.

Thomas TZ, Chapman SM, Hong W, Gurusingfhe C, Mellor SL, Fletcher R, Pedersen J, Risbridger GP. Thomas TZ, et al. Among authors: mellor sl. Prostate. 1998 Jan 1;34(1):34-43. doi: 10.1002/(sici)1097-0045(19980101)34:1<34::aid-pros5>3.0.co;2-k. Prostate. 1998. PMID: 9428386

4

Expression of activin A and follistatin core proteins by human prostate tumor cell lines.

McPherson SJ, Mellor SL, Wang H, Evans LW, Groome NP, Risbridger GP. McPherson SJ, et al. Among authors: mellor sl. Endocrinology. 1999 Nov;140(11):5303-9. doi: 10.1210/endo.140.11.7141. Endocrinology. 1999. PMID: 10537161

5

Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit.

Mellor SL, Cranfield M, Ries R, Pedersen J, Cancilla B, de Kretser D, Groome NP, Mason AJ, Risbridger GP. Mellor SL, et al. J Clin Endocrinol Metab. 2000 Dec;85(12):4851-8. doi: 10.1210/jcem.85.12.7052. J Clin Endocrinol Metab. 2000. PMID: 11134153

6

The contribution of inhibins and activins to malignant prostate disease.

Risbridger GP, Mellor SL, McPherson SJ, Schmitt JF. Risbridger GP, et al. Among authors: mellor sl. Mol Cell Endocrinol. 2001 Jun 30;180(1-2):149-53. doi: 10.1016/s0303-7207(01)00497-x. Mol Cell Endocrinol. 2001. PMID: 11451585 Review.

7

Re-evaluation of inhibin alpha subunit as a tumour suppressor in prostate cancer.

Risbridger GP, Ball EM, Wang H, Mellor SL, Peehl DM. Risbridger GP, et al. Among authors: mellor sl. Mol Cell Endocrinol. 2004 Oct 15;225(1-2):73-6. doi: 10.1016/j.mce.2004.02.015. Mol Cell Endocrinol. 2004. PMID: 15451570

8

Activin betaC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate.

Mellor SL, Ball EM, O'Connor AE, Ethier JF, Cranfield M, Schmitt JF, Phillips DJ, Groome NP, Risbridger GP. Mellor SL, et al. Endocrinology. 2003 Oct;144(10):4410-9. doi: 10.1210/en.2003-0225. Epub 2003 Jun 26. Endocrinology. 2003. PMID: 12960042

9

Regulation of prostate branching morphogenesis by activin A and follistatin.

Cancilla B, Jarred RA, Wang H, Mellor SL, Cunha GR, Risbridger GP. Cancilla B, et al. Among authors: mellor sl. Dev Biol. 2001 Sep 1;237(1):145-58. doi: 10.1006/dbio.2001.0364. Dev Biol. 2001. PMID: 11518512 Free article.

10

Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis.

Gold EJ, Francis RJ, Zimmermann A, Mellor SL, Cranfield M, Risbridger GP, Groome NP, Wheatley AM, Fleming JS. Gold EJ, et al. Among authors: mellor sl. Mol Cell Endocrinol. 2003 Mar 28;201(1-2):143-53. doi: 10.1016/s0303-7207(02)00417-3. Mol Cell Endocrinol. 2003. PMID: 12706302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters